Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 30 Biotech Angel Investors in Spain in July 2025

Last updated: Jul 2025 A list of 30 angel investors that invest in Biotech startups based in Spain. We rank investors based on the number of investments they made in Biotech companies from Spain. We update this investor list every month.

Top 30 Biotech Angel Investors in Spain in July 2025

Investor	Biotech Spain investments
Alberto Hospital Marco	2
Gus Bertolo	2
Juan Knuth	2
Fabio Núñez	2
Roberto Conde Penas	1
Roberto Pomares	1
Santiago Domínguez	1
Vicente Durán	1
Milad Alucozai	1
Ryan Bethencourt	1
Mario Pablo Sánchez Barrón	1
Pedro Lizondo Siguero	1
Mercedes Gonzalez Gorbena	1
Fernando García Abasolo	1
Juanjo Mostazo	1
David Brandes	1
Arman Anatürk	1
Alfons Hidalgo	1
Arnaldo Marziali	1
Torres Quevedo	1
Montserrat Esteve	1
José Luis del Río Galán	1
Mauricio Peralta	1
Jonathan Milner	1
Mariliis Holm	1
Arturo Elizondo	1
Others Others	1
Javier Alsina	1
Ritu Bansal-Mutalik	1
Inaki Berenguer	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Alberto Hospital Marco

Investment focus

SaaS, Software, Logistics
Seed
Spain

Portfolio highlights

Freightol — Freightol is a technological startup with the mission to digitize the transport and logistics industry. To make this industry more innovative and efficient, we used Freightol Manager, a complete digital platform that digitizes all parts of a Global Freight Forwarder: its logistical operations, handling and management of shipments, quotations,billing and customs, from the beginning to the end in real time.
Insectius — Insectius uses artificial intelligence (AI) in insect breeding, management, and manufacture of insect flour.

Gus Bertolo

Investment focus

Software, Biotechnology, Artificial Intelligence
Seed
Spain

Portfolio highlights

Insectius — Insectius uses artificial intelligence (AI) in insect breeding, management, and manufacture of insect flour.

Juan Knuth

Investment focus

Health Care, Biotechnology, Digital Media
Seed, Series A
Spain

Portfolio highlights

Devicare — Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The company's medical devices are useful in measuring the level of biomarkers in body fluids such as saliva, tears, sweat, sputum, feces, urine or blood, enabling medical professionals to detect and treat various infectious diseases.

Fabio Núñez is an Angel Investor.

Investment focus

Software, Biotechnology, Artificial Intelligence
Seed
Spain

Portfolio highlights

Insectius — Insectius uses artificial intelligence (AI) in insect breeding, management, and manufacture of insect flour.

Roberto Conde Penas

Investment focus

Biotechnology
Seed
Spain

Portfolio highlights

Smart Vitamins — Smart Vitamins is a biotechnology company that develops innovative formulations in the pharmaceutical, cosmetic, and nutraceutical sectors.

Roberto Pomares is the managing partner of Addleshaw Goddar Spain.

Investment focus

Biotechnology
Seed
Spain

Portfolio highlights

Smart Vitamins — Smart Vitamins is a biotechnology company that develops innovative formulations in the pharmaceutical, cosmetic, and nutraceutical sectors.

Santi is CEO and cofounder of Mestrelab Research SL. He also cofounded and is a director of IMSPEX Diagnostics Ltd. and is a board member of eMolecules Inc. Santi grew up in Santiago de Compostela, and graduated in Business Studies at Santiago de Compostela University in 1995. He started his professional career in 1995 at NCH Corporation, aspecialty chemicals multinational company where he held Sales, Sales Management and General Management positions. After 10 years, he left NCH to cofound Mestrelab, where he has responsibilities in many areas of the business, including Sales, Business Development and R&D. Through his activity at Mestrelab and his other roles, Santi has developed extensive skills in analytical chemistry, general management, international commerce, software R&D project management, e-commerce, M&A and hardware development and manufacturing. His interest outside work include fiction and economics writing and a number of sports, including skiing, athletics and a particular passion for cycling and rugby.

Investment focus

Biotechnology
Seed
Spain

Portfolio highlights

Smart Vitamins — Smart Vitamins is a biotechnology company that develops innovative formulations in the pharmaceutical, cosmetic, and nutraceutical sectors.

Vicente Durán is the president of the Medpoint group.

Investment focus

Biotechnology
Seed
Spain

Portfolio highlights

Smart Vitamins — Smart Vitamins is a biotechnology company that develops innovative formulations in the pharmaceutical, cosmetic, and nutraceutical sectors.

Dr. Milad Alucozai specializes in translating scientific and technological breakthroughs into scalable commercial ventures. As an Afghan-American neuroscientist, entrepreneur, and global investor, he leverages his expertise in bioengineering, computational biology, and machine learning to identify promising innovations and develop strategies fortheir successful market entry and growth. He focuses on accelerating the process of bringing groundbreaking discoveries from the lab to market, particularly in the life sciences and computationally-driven fields.Dr. Alucozai is a co-founder of Revalia Bio, which aims to create a human-centric infrastructure for drug discovery and development. By utilizing non-transplantable human organs donated for research, Revalia provides the scientific community unparalleled insights into patient biology, ultimately aiding in the development of better treatments and cures. In 2024, he partnered with The Wyss Institute at Harvard University to launch and co-host the popular "Code to Cure" series, exploring the convergence of AI, biology, and healthcare. He also contributes his expertise as a Senior Fellow in Healthcare Engineering at the Regenstrief Center.His background includes leading 70 early-stage investments as Head of Bio and Deep Tech at BoxOne Ventures, establishing the firm as a key player in North America's VC landscape. He also served as a Venture Partner at Entrepreneur First, a globally recognized talent investor backed by notable figures like Patrick and John Collison of Stripe and Reid Hoffman of LinkedIn, with a portfolio exceeding $10 billion in value. He mentors entrepreneurs across North America and Europe through channels like the Creative Destruction Lab.Throughout his operating and investing career, he has been instrumental in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. Often serving as the first investor, he guides companies from concept to successful exit and shapes business development for high-growth, venture-backed startups. His advisory work also extends to established corporations; at Accenture, he led teams advising top pharmaceutical companies on their R&D, innovation, and business development strategies. In 2020, he formally served as an External Advisor to AstraZeneca.He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a Neuroscience degree from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a visiting scholarship at the Wyss Institute at Harvard University.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, Canada, United Kingdom

Portfolio highlights

Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.

Ryan is a co-founder and CEO at Wild Earth and a co-founder and Partner at Sustainable Food Ventures, bringing years of experience in leading, building and advising high-growth food and biotechnology companies. Ryan is a biotech entrepreneur, investor, and one of the founders of the biohacker movement. He’s a co-founder and former Program Directorat IndieBio and has invested in over 130 early stage biotech startups and served as the head of life sciences at the XPRIZE Foundation. As an ethical vegan, Ryan is passionate about the future of biology as a technology, applied across all industries to solve some of humanity’s most intractable problems. Ryan fosters dogs for Rocket Dog Rescue and is passionate about mindfulness, meditation, and mentoring. His work at the interface of science, food, and business has been covered by many major publications.

Investment focus

Biotechnology, Food Processing, Food and Beverage
Pre-Seed, Seed, Angel
United States, Chile, India

Portfolio highlights

WTH Foods — WTH Foods is a plant-based alternative protein company based in Manila, Philippines. Using local and sustainable ingredients, we create plant-based versions of processed meat products that Southeast Asian love
Sobo Foods — Sobo Foods is a plant based comfort food provider.
Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI

Mario Pablo Sánchez Barrón , CEO of Startidea.

Investment focus

EdTech, Children, Education
Pre-Seed
Spain

Portfolio highlights

Neuromindset — In an ever-evolving digital era, the mental abilities and emotional health of children often get overshadowed. Envision a world where the essence of education transcends mere knowledge, nurturing every child to unlock their cognitive and emotional prowess using evidence-based tools. At Neuromindset, a Spin-off of the University of Granada (Spain),this isn't just a dream—it's our mission. Our purpose? Seamlessly integrate cognitive and brain training into the very fabric of schooling and home environments. Our dual B2B and B2C models cater to educators and families alike, fortified by three pioneering instruments. Firstly, a classroom-integrated platform that provides educators with a training curriculum that includes mindfulness and game-based activities grounded in rigorous neuroscientific research, empowering students to enhance their attention, executive functions and self-regulation. Secondly, an interactive at-home gaming app, meticulously crafted to cultivate cognitive prowess, making the training both captivating and consequential. And lastly, our avant-garde AI assessment of attentional profiles, not just delineating a child's cognitive map but also tailoring their training, fortifying frailties, and magnifying mights. Neuromindset's hallmark is our dedication to fortify children's mental well-being, bolstering self-regulation, and providing AI-infused, personalized cognitive training. With Neuromindset, education it's not just about learning—it's about flourishing in every sense.

Pedro Lizondo seguiro is an individual investor.

Investment focus

EdTech, Children, Education
Pre-Seed
Spain

Portfolio highlights

Neuromindset — In an ever-evolving digital era, the mental abilities and emotional health of children often get overshadowed. Envision a world where the essence of education transcends mere knowledge, nurturing every child to unlock their cognitive and emotional prowess using evidence-based tools. At Neuromindset, a Spin-off of the University of Granada (Spain),this isn't just a dream—it's our mission. Our purpose? Seamlessly integrate cognitive and brain training into the very fabric of schooling and home environments. Our dual B2B and B2C models cater to educators and families alike, fortified by three pioneering instruments. Firstly, a classroom-integrated platform that provides educators with a training curriculum that includes mindfulness and game-based activities grounded in rigorous neuroscientific research, empowering students to enhance their attention, executive functions and self-regulation. Secondly, an interactive at-home gaming app, meticulously crafted to cultivate cognitive prowess, making the training both captivating and consequential. And lastly, our avant-garde AI assessment of attentional profiles, not just delineating a child's cognitive map but also tailoring their training, fortifying frailties, and magnifying mights. Neuromindset's hallmark is our dedication to fortify children's mental well-being, bolstering self-regulation, and providing AI-infused, personalized cognitive training. With Neuromindset, education it's not just about learning—it's about flourishing in every sense.

Mercedes Gonzalez-Gorbena is the Chief Product Officer at TES Global.

Investment focus

EdTech, Children, Education
Pre-Seed
Spain

Portfolio highlights

Neuromindset — In an ever-evolving digital era, the mental abilities and emotional health of children often get overshadowed. Envision a world where the essence of education transcends mere knowledge, nurturing every child to unlock their cognitive and emotional prowess using evidence-based tools. At Neuromindset, a Spin-off of the University of Granada (Spain),this isn't just a dream—it's our mission. Our purpose? Seamlessly integrate cognitive and brain training into the very fabric of schooling and home environments. Our dual B2B and B2C models cater to educators and families alike, fortified by three pioneering instruments. Firstly, a classroom-integrated platform that provides educators with a training curriculum that includes mindfulness and game-based activities grounded in rigorous neuroscientific research, empowering students to enhance their attention, executive functions and self-regulation. Secondly, an interactive at-home gaming app, meticulously crafted to cultivate cognitive prowess, making the training both captivating and consequential. And lastly, our avant-garde AI assessment of attentional profiles, not just delineating a child's cognitive map but also tailoring their training, fortifying frailties, and magnifying mights. Neuromindset's hallmark is our dedication to fortify children's mental well-being, bolstering self-regulation, and providing AI-infused, personalized cognitive training. With Neuromindset, education it's not just about learning—it's about flourishing in every sense.

Fernando García Abásolo is a businessman passionate about neuroscience and innovation to improve the potential of children.

Investment focus

EdTech, Children, Education
Pre-Seed
Spain

Portfolio highlights

Neuromindset — In an ever-evolving digital era, the mental abilities and emotional health of children often get overshadowed. Envision a world where the essence of education transcends mere knowledge, nurturing every child to unlock their cognitive and emotional prowess using evidence-based tools. At Neuromindset, a Spin-off of the University of Granada (Spain),this isn't just a dream—it's our mission. Our purpose? Seamlessly integrate cognitive and brain training into the very fabric of schooling and home environments. Our dual B2B and B2C models cater to educators and families alike, fortified by three pioneering instruments. Firstly, a classroom-integrated platform that provides educators with a training curriculum that includes mindfulness and game-based activities grounded in rigorous neuroscientific research, empowering students to enhance their attention, executive functions and self-regulation. Secondly, an interactive at-home gaming app, meticulously crafted to cultivate cognitive prowess, making the training both captivating and consequential. And lastly, our avant-garde AI assessment of attentional profiles, not just delineating a child's cognitive map but also tailoring their training, fortifying frailties, and magnifying mights. Neuromindset's hallmark is our dedication to fortify children's mental well-being, bolstering self-regulation, and providing AI-infused, personalized cognitive training. With Neuromindset, education it's not just about learning—it's about flourishing in every sense.

Juanjo Mostazo

Investment focus

Artificial Intelligence, B2B, Mobile Apps
Seed, Pre-Seed, Angel
Spain, Colombia

Portfolio highlights

WATIF — WATIF is the media that investigates how current trends can impact tomorrow's world. It focused on culture, work, science, and technology.
Kuikads — Kuikads enables businesses to create and distribute personalized marketing videos via API using user data across messaging.
Tu Trámite Fácil — Tu Trámite Fácil is a startup designed to simplify access to public grants, subsidies, and financial aid for individuals and businesses

David Brandes - Managing Director & Co-Founder @ Peace of Meat

Investment focus

Wellness, Life Science, Biotechnology
Seed
Spain

Portfolio highlights

Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI

Arman Anatürk is Co-Founder @ FoodHack.

Investment focus

Biotechnology, Food and Beverage, Wellness
Seed, Pre-Seed
Spain, Israel, Germany

Portfolio highlights

Bosque Foods — Kinoko Labs develops the next generation of meat substitutes, starting with whole-cut meat items made from fungal mycelium produced organically. Headquartered in New York.
Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.

Alfons Hidalgo

Investment focus

Medical, Biopharma, Life Science
Funding Round
Spain

Portfolio highlights

Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer

Arnaldo Marziali

Investment focus

Big Data, Software, Life Science
Pre-Seed
Spain

Portfolio highlights

Seqera — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).

Torres Quevedo

Investment focus

Biopharma, Therapeutics, Biotechnology
Seed
Spain

Portfolio highlights

Oniria Therapeutics — Modulating cell dormancy to overcome cancer persistence

Montserrat Esteve

Investment focus

Health Care, Neuroscience, Biotechnology
Seed
Spain

Portfolio highlights

FreeOx Biotech — Based on the knowledge of oxidative stress and uric acid, Freeox Biotech is developing neuroprotective therapies to reduce the damage resulting from ischemia and in this way improve the recovery of the patients. Ox-01 is Uric Acid used as a medicinal product. Ox-01 has a proven effect in preventing the damage caused by reperfusion after stroke.Ox-02 Uricoline is a molecule resulting from the association of Ox-01 and Citicoline. Citicoline is an intermediate in the generation of phosphatidylcholine from choline.

José Luis del Río Galán

Investment focus

Biotechnology
Seed
Spain

Portfolio highlights

Smart Vitamins — Smart Vitamins is a biotechnology company that develops innovative formulations in the pharmaceutical, cosmetic, and nutraceutical sectors.

Mauricio Peralta

Investment focus

Biotechnology
Seed
Spain

Portfolio highlights

Smart Vitamins — Smart Vitamins is a biotechnology company that develops innovative formulations in the pharmaceutical, cosmetic, and nutraceutical sectors.

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
United Kingdom, United States, Spain

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Exciting Instruments — We're on a mission to simplify single-molecule fluorescence spectroscopy and make it accessible to all. Find out more about our company, our products and what makes us different now.

I am a food scientist, entrepreneur and investor. Through SFV (sustainablefoodventures.com), I back founders building the future of cell-based, plant-based and recombinant food.

Investment focus

Food Processing, Seafood, Wellness
Pre-Seed, Angel
Spain, Iceland, United States

Portfolio highlights

Loki Foods — We're producing sustainable, plant-based foods from the Arctic. Iceland’s first plant-based cod and seafood!
Sobo Foods — Sobo Foods is a plant based comfort food provider.
Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI

Arturo Elizondo is CEO of Clara Foods, a sustainable ingredients company making the world’s most comprehensive egg white substitute. Clara leverages advances in fermentation technology to bring an egg white to the table that is completely animal-free, far more sustainable, and free of salmonella without compromising the qualities we know and love.Prior to joining Clara Foods, Arturo worked at the investment bank Credit Suisse, U.S. Department of Agriculture, and under Supreme Court Justice Sonia Sotomayor.

Investment focus

Wellness, Life Science, Biotechnology
Seed, Pre-Seed
Spain, Switzerland

Portfolio highlights

Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence

Others Others

Investment focus

Biotechnology, Software, B2B
Seed, Pre-Seed, Funding Round
Spain, Germany, Ireland

Portfolio highlights

Conektto — Design, Build & Test API in minutes. Conektto is the industry's first API SDLC platform that intelligently generates artifacts.
Gheorg — Around 1 million children in Australia have diagnosable anxiety. Two-thirds of them will never get the help they need. Gheorg is on a mission to change that. We're aiming to reduce childhood anxiety and our new app helps parents and children at home. Sign up to get the app on our website.
Hooke Bio — Hooke Bio is a new Pharmaceutical company operating in the preclinical to early stages of drug discovery. It draws its strength from the close co-operation it has between its biologists and engineers. The engineers design, patent and test new microfluidic technology: the scientists apply the technology to finding new therapeutics.

Javier Alsina

Investment focus

Health Care, Neuroscience, Biotechnology
Seed
Spain

Portfolio highlights

FreeOx Biotech — Based on the knowledge of oxidative stress and uric acid, Freeox Biotech is developing neuroprotective therapies to reduce the damage resulting from ischemia and in this way improve the recovery of the patients. Ox-01 is Uric Acid used as a medicinal product. Ox-01 has a proven effect in preventing the damage caused by reperfusion after stroke.Ox-02 Uricoline is a molecule resulting from the association of Ox-01 and Citicoline. Citicoline is an intermediate in the generation of phosphatidylcholine from choline.

Ritu Bansal-Mutalik is a Senior Director, Process Research and Development at ZymoChem.

Investment focus

Wellness, Life Science, Biotechnology
Seed
Spain

Portfolio highlights

Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI

Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.

Investment focus

E-Commerce, FinTech, Financial Services
Seed, Angel, Pre-Seed
Spain, United States, United Kingdom

Portfolio highlights

Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
Bankflip — Permissioned data technology to collect and process your customers' income, tax, employment & other relevant data & documents in real-time
Mable (Neurolytic Healthcare) — Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions.The company delivers digitally and genomically-drivenmedical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.

Investors by industry